Sample size and power considerations for cluster randomized trials with count outcomes subject to right truncation
Cluster randomized trials (CRTs) are widely used in epidemiological and public health studies assessing population‐level effect of group‐based interventions. One important application of CRTs is the control of vector‐borne disease, such as malaria. However, a particular challenge for designing these...
Saved in:
Published in | Biometrical journal Vol. 63; no. 5; pp. 1052 - 1071 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Germany
Wiley - VCH Verlag GmbH & Co. KGaA
01.06.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Cluster randomized trials (CRTs) are widely used in epidemiological and public health studies assessing population‐level effect of group‐based interventions. One important application of CRTs is the control of vector‐borne disease, such as malaria. However, a particular challenge for designing these trials is that the primary outcome involves counts of episodes that are subject to right truncation. While sample size formulas have been developed for CRTs with clustered counts, they are not directly applicable when the counts are right truncated. To address this limitation, we discuss two marginal modeling approaches for the analysis of CRTs with truncated counts and develop two corresponding closed‐form sample size formulas to facilitate the design of such trials. The proposed sample size formulas allow investigators to explore the power under a large number of scenarios without computationally intensive simulations. The proposed formulas are validated in extensive simulations. We further explore the implication of right truncation on power and apply the proposed formulas to illustrate the power calculation for a malaria control CRT where the primary outcome is subject to right truncation. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-3 ObjectType-Evidence Based Healthcare-1 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0323-3847 1521-4036 1521-4036 |
DOI: | 10.1002/bimj.202000230 |